SCHEMBL4757060

SCHEMBL4757060

CCC(CC)S(=O)(=O)c1csc(NC(=O)c2cc(C)ccc2OC(C)=O)n1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GCK P35557 4/20 0.37
HSD17B10 Q99714 2/20 0.37
LMNA P02545 2/20 0.37
NPSR1 Q6W5P4 1/20 0.37
SORT1 Q99523 1/20 0.36
KDM4E B2RXH2 2/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
MITF O75030 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
RXFP1 Q9HBX9 1/20 0.35
MEN1 O00255 5/20 0.35
KMT2A Q03164 5/20 0.35
ALDH1A1 P00352 3/20 0.35
POLB P06746 1/20 0.35
HTT P42858 2/20 0.35
MAPK1 P28482 1/20 0.35
GAA P10253 2/20 0.35
PKM P14618 1/20 0.35
TP53 P04637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4757296 0.92 KDM4E (0.40) GCKHSD17B10LMNANPSR1SORT1
SCHEMBL4931674 0.90 GCK (0.41) GCKHSD17B10LMNANPSR1KDM4E
SCHEMBL12974190 0.86 GCK (0.41) GCKHSD17B10NPSR1SORT1KDM4E
SCHEMBL10114598 0.85 KDM4E (0.41) GCKHSD17B10LMNANPSR1KDM4E
SCHEMBL12994116 0.76 KDM4E (0.48) GCKHSD17B10LMNANPSR1KDM4E
SCHEMBL12994105 0.76 ALDH1A1 (0.47) GCKHSD17B10LMNANPSR1KDM4E
SCHEMBL2697848 0.75 SORT1 (0.39) GCKHSD17B10LMNANPSR1SORT1
SCHEMBL12974198 0.74 ALDH1A1 (0.48) GCKHSD17B10LMNANPSR1KDM4E
SCHEMBL4756830 0.73 ABL1 (0.38) GCKLMNAKDM4ENPC1RAB9A
SCHEMBL703188 0.72 ALDH1A1 (0.50) GCKHSD17B10LMNANPSR1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES, L.C. 2012-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC GCK 1360/4885HSD17B10 921/4885LMNA 2943/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.